Lutein/omega-3 polyunsaturated fatty acids/zeaxanthin Drug Interactions
Currently displaying a list of 77 drugs known to interact with lutein / omega-3 polyunsaturated fatty acids / zeaxanthin.
- 76 moderate drug interactions
- 1 minor drug interaction
Medications known to interact with lutein/omega-3 polyunsaturated fatty acids/zeaxanthin
Note: Showing generic names only.
A
- abciximab
- alteplase
- anagrelide
- anisindione
- anistreplase
- antithrombin (recombinant)
- antithrombin iii
- apixaban
- ardeparin
- argatroban
- aspirin
B
C
D
- dabigatran
- dalteparin
- danaparoid
- defibrotide
- desirudin
- dextran 1
- dextran, high molecular weight
- dextran, low molecular weight
- diclofenac
- dicumarol
- diflunisal
- dipyridamole
- drotrecogin alfa
E
F
H
I
K
L
M
N
O
P
R
S
T
U
V
W
Lutein/omega-3 polyunsaturated fatty acids/zeaxanthin disease interactions
There are 2 disease interactions with lutein / omega-3 polyunsaturated fatty acids / zeaxanthin which include:
Report options
QR code containing a link to this page
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.